Gene · 4261
Papers3,496
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,496
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Banking on virus-specific T cells to fulfill the need for off-the-shelf cell therapies. | Blood | 2023 | 36574622 | PubTator, text mining | PubMed |
| Tumor cells fail to present MHC-II-restricted epitopes derived from oncogenes to CD4+ T cells. | JCI Insight | 2023 | 36512410 | PubTator, text mining | PubMed |
| Ewing and Ewing-like sarcomas: A morphological guide through genetically-defined entities. | Pathol Int | 2023 | 36484765 | PubTator, text mining | PubMed |
| Mechanisms and application strategies of miRNA‑146a regulating inflammation and fibrosis at molecular and cellular levels (Review). | Int J Mol Med | 2023 | 36484394 | PubTator, text mining | PubMed |
| Cellular mechanisms and molecular pathways linking bitter taste receptor signalling to cardiac inflammation, oxidative stress, arrhythmia and contractile dysfunction in heart diseases. | Inflammopharmacology | 2023 | 36471190 | PubTator, text mining | PubMed |
| A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomas. | Leukemia | 2023 | 36460764 | PubTator, text mining | PubMed |
| Activation priming and cytokine polyfunctionality modulate the enhanced functionality of low-affinity CD19 CAR T cells. | Blood Adv | 2023 | 36453632 | PubTator, text mining | PubMed |
| Association of Interleukin 6 Inhibition With Ziltivekimab and the Neutrophil-Lymphocyte Ratio: A Secondary Analysis of the RESCUE Clinical Trial. | JAMA Cardiol | 2023 | 36449307 | PubTator, text mining | PubMed |
| IgG memory B cells expressing IL4R and FCER2 are associated with atopic diseases. | Allergy | 2023 | 36445014 | PubTator, text mining | PubMed |
| The role of noncoding RNAs in the osteogenic differentiation of human periodontal ligament-derived cells. | Noncoding RNA Res | 2023 | 36439972 | PubTator, text mining | PubMed |
| Feasibility and Potential of Transcriptomic Analysis Using the NanoString nCounter Technology to Aid the Classification of Rejection in Kidney Transplant Biopsies. | Transplantation | 2023 | 36413151 | PubTator, text mining | PubMed |
| Genomic Profiling Reveals Differences in Primary Central Nervous System Lymphoma and Large B-Cell Lymphoma, With Subtyping Suggesting Sensitivity to BTK Inhibition. | Oncologist | 2023 | 36342081 | PubTator, text mining | PubMed |
| The duality of STAT2 mediated type I interferon signaling in the tumor microenvironment and chemoresistance. | Cytokine | 2023 | 36327541 | PubTator, text mining | PubMed |
| Engineered and banked iPSCs for advanced NK- and T-cell immunotherapies. | Blood | 2023 | 36327161 | PubTator, text mining | PubMed |
| Mitogen-activated protein kinase inhibition augments the T cell response against HOXB7-expressing tumor through human leukocyte antigen upregulation. | Cancer Sci | 2023 | 36285482 | PubTator, text mining | PubMed |
| A gene regulatory network approach harmonizes genetic and epigenetic signals and reveals repurposable drug candidates for multiple sclerosis. | Hum Mol Genet | 2023 | 36282535 | PubTator, text mining | PubMed |
| Molecular landscape of immune pressure and escape in aplastic anemia. | Leukemia | 2023 | 36253429 | PubTator, text mining | PubMed |
| Identification of small molecule modulators of class II transactivator-I using computational approaches. | J Biomol Struct Dyn | 2023 | 36224172 | PubTator, text mining | PubMed |
| Synthetic Biology Technologies And Genetically Engineering Strategies For Enhanced Cell Therapeutics. | Stem Cell Rev Rep | 2023 | 36166137 | PubTator, text mining | PubMed |
| Disease-Defining Molecular Features of Primary Cutaneous B-Cell Lymphomas: Implications for Classification and Treatment. | J Invest Dermatol | 2023 | 36163302 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4261/papers?page=28